Are you driven by the idea of working in a scientific environment that offers both independence and open collaboration? Join us as we follow the data to unlock the potential of cortisol modulation to treat serious diseases. https://bit.ly/3V4V5PX #CortisolModulation #Endocrinology #Oncology
Corcept Therapeutics’ Post
More Relevant Posts
-
What began as a ripple of scientific truth is poised to unleash a sea change of discovery. Learn how: https://www.corcept.com/ #CortisolModulation #endocrinology #oncology #metabolism #neurology
-
Final results from the prevalence phase of our phase IV clinical trial study of hypercortisolism (Cushing’s syndrome) in patients with difficult-to-control type 2 diabetes were presented today at the American Diabetes Association 84th Scientific Sessions. Read more: https://lnkd.in/g_SbwHCT #CortisolModulation #Diabetes #Type2Diabetes #ADASciSessions #Hypercortisolism
-
-
Today at ADA our CATALYST data are being presented in the session: ADA Catalyst Plenary - Prevalence of Hypercortisolism in Difficult to Control Type 2 Diabetes. We look forward to the insightful discussion, which will be held in W415B (Valencia Ballroom) from 3:15pm – 4:15pm EDT. American Diabetes Association #CortisolModulation #Diabetes #ADASciSessions #Hypercortisolism
-
-
We are delighted to introduce our 2024 Summer Intern class! They bring a wide array of educational expertise including studies in law, finance, data science, economics, biology, psychology, biochemistry, and engineering. We eagerly welcome their enthusiasm and innovative ideas as they lead initiatives across several functions and departments in the organization. Join us in welcoming them to the Corcept team!
-
-
You’ll find us this week at the American Diabetes Association’s 84th Scientific Sessions in Orlando! Visit us at booth #401. #CortisolModulation #Diabetes #ADASciSessions
This content isn’t available here
Access this content and more in the LinkedIn app
-
Today at the 8th annual Heart in Diabetes we’re sharing more information about our GRACE clinical trial data in our presentation: Medical Treatment of Hypercortisolism with Relacorilant: Final Results of the Phase 3 GRACE Study. Metabolic Endocrine Education Foundation #CortisolModulation #8thHeartinDiabetes #HID2024
-
-
Highlighting contributions from scientists who identify as LGBTQ+ not only breaks stereotypes but also provides crucial role models for future generations, promoting inclusivity and innovation in scientific communities. To honor #PrideMonth, Corcept celebrates the work of Dr. Neena Schwartz, an endocrinologist who identified as a lesbian. Learn more about her life here: https://bit.ly/3x0mY3D
-
-
The upcoming presentations on GRACE data at #ENDO2024 and Heart in Diabetes will offer more context for providers who manage patients living with #hypercortisolism https://bit.ly/4aLaVoz Endocrine Society Metabolic Endocrine Education Foundation #8thHeartinDiabetes #HID2024 #CortisolModulation #Endocrinology #CushingsSyndrome #CortisolModulation
-
-
We couldn’t let #ALSAwarenessMonth wrap without our annual company walk! The event gives our employees the opportunity to raise critical awareness about ALS – and reminds us all of the importance of our work that aims to address this serious disease. We heard moving and educational presentations from Sheri Strahl at the ALS Network and Dr. Michael Robinson, who spoke about the first-hand challenges faced by people before and after diagnosis. We remain in awe of the critical advocacy work led by ALS Network, Michael and the many individuals and groups dedicating their lives to helping people with ALS.
-
